[Form 4] MADRIGAL PHARMACEUTICALS, INC. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Madrigal Pharmaceuticals director Rebecca Taub reported new equity awards. She received 454 restricted stock units that vest on the earlier of June 17, 2027 or the company’s 2027 annual meeting, if she remains in service. She was also granted a stock option for 766 shares of common stock at an exercise price of $499.86 per share, expiring on June 17, 2036, with the same vesting schedule. Following these awards, she holds 452,667 shares of common stock directly and 655,540 shares indirectly through SQN LLC, where she and her spouse are managing members and she disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Taub Rebecca
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 766 | $0.00 | -- |
| Grant/Award | Common Stock | 454 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 766 shares (Direct, null);
Common Stock — 452,667 shares (Direct, null);
Common Stock — 655,540 shares (Indirect, By SQN LLC)
Footnotes (1)
- Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date. The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date.
Key Figures
Restricted stock units granted: 454 units
Stock options granted: 766 options
Option exercise price: $499.86 per share
+3 more
6 metrics
Restricted stock units granted
454 units
RSU award vesting by June 17, 2027 or 2027 annual meeting
Stock options granted
766 options
Option grant on common stock vesting by June 17, 2027
Option exercise price
$499.86 per share
Exercise price for 766-share stock option grant
Option expiration
June 17, 2036
Expiration date of the 766-share stock option
Direct common shares after grant
452,667 shares
Direct Madrigal holdings reported following equity awards
Indirect common shares via SQN LLC
655,540 shares
Indirect holdings reported through SQN LLC
Key Terms
restricted stock units, Stock Option (Right to Buy), pecuniary interest, beneficial ownership, +1 more
5 terms
restricted stock units financial
"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an underlying security title of Common Stock"
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein"
beneficial ownership financial
"the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
